’DPCO 2013 will equally affect domestic as well multinational pharma companies’
The DPCO 2013 aims to put in place a regulatory framework for pricing of drugs so as to ensure availability of 'essential…
Author
Low hiring sentiments in pharma sector
However, the hiring activity in the sector is 24 per cent higher than what it was an year ago
IPM registers growth of 9.3 per cent in April 2013, valued at Rs 6239 crores
From therapeutic perspective, 10 therapies have outgrown the IPM story
Minister for Health & Family Welfare denies report on clinical trials conducted on new borns
Emphasises role of trials to establish safety and efficacy of new drugs
A paucity of perception
A fortnight after the Supreme Court of India delivered its judgment in the Novartis/ Glivec case
Access to medicines: Beyond 2Ps
While price and patents have for long been considered as the two barriers impeding access to medicines, the issue extends far…
Pentavalent vaccine: Doing more harm than good?
Jacob Puliyel, Head of Pediatrics, St Stephens Hospital Delhi, questions whether the time has come to stop using Pentavalent…
The TB Armamentarium
With riding incidence of TB, Domestic and MNC pharma are trying to dominate the anti-TB market. As a result, around 15 new drugs…